Nav: Home

Boost for lipid research: Austrian researchers facilitate lipid data analysis

October 23, 2017

No lipids, no life. In all organisms, lipids form cell walls, store energy and release it when necessary, and play an important role in cell signalling. It has been proved that changes in the composition of lipids play a causal role in illnesses such as cancer, fatty liver and multiple sclerosis. According to rough estimates, there are about 300,000 different lipid species. For the detection of lipids indicative for diseases, healthy and sick organisms are typically compared quantitatively. This comparison requires reliable and detailed information about the structure and composition of lipids from tissue samples - and to this end researchers from the BioTechMed-Graz initiative have developed a tool which is presented in the current issue of Nature Methods.

Lipids with character

Lipids - often just called fats - are complex substances which in addition to various other components predominantly consist of fatty acids. In lipid research, however, there are still many things unknown. Also, the detection of structural properties of lipid molecules in high-throughput profiling is still in its infancy. In the presented high-throughput method, a large number of samples are measured using mass spectrometry. These data (i.e., spectra) provide information for identification of the type and class of lipid or the type and position of the fatty acyl chains. However, the measured spectra can differ between one and the same lipid species, because lipids show different fragments in the spectra depending on the setup of the mass spectrometer and the ionization. Due to this spectral diversity, up to now there has been no universally applicable bioinformatics software for the automated detection of lipid structures.

Gerhard Thallinger of TU Graz's Institute of Computational Biotechnology explains the necessity of automated lipid characterisation: "Fast and reliable details on the lipid composition of cell samples are a prerequisite for comparisons with reference samples from healthy cells - which are required for the detection of biomarkers characteristic for diseases. The important question is which changes in the lipid composition of cells are relevant in diagnostics?"

The "Lipid Data Analyzer", which researchers of TU Graz, Med Uni Graz and University of Graz have published in Nature Methods, will facilitate work tremendously in biomedical research and definitely accelerate lipid research - of this Jürgen Hartler, also at the Institute of Computational Biotechnology, is convinced: "The method which we have developed in collaboration with colleagues from Med Uni Graz and Uni Graz, interprets lipid spectra using intuitive rule sets and can be as such flexibly accommodated to various fragmentation characteristics. This makes it possible for the first time to identify lipids at a very detailed structural level more precisely and reliably than previous solutions." The TU Graz team was responsible for the software development, the mass spectrometric experiments and usability tests were carried out at the Center for Medical Research (ZMF) of the Medical University of Graz and the University of Graz, and biological experiments were carried out at the University of Graz.

Extendable to other metabolic products such as sugars

In the presented study, the Lipid Data Analyzer detected more than 100 novel lipid species, which were previously unreported. The tool can be flexibly adapted - and not just for new classes of lipids. It may be used, for instance, to characterise polysaccharides and glycolipids, i.e. lipids with attached sugars. The researchers provide their Lipid Data Analyzer as open source to the scientific community.
-end-
About the Nature Methods paper:

Deciphering lipid structures based on platform-independent decision rules. J. Hartler*, A. Triebl*, A. Ziegl, M. Trötzmüller, G.N. Rechberger, O.A. Zeleznik, K.A. Zierler, F. Torta. A. Cazenave-Gassiot, M.R. Wenk, A. Fauland, C.E. Wheelock, A.M. Armando, O. Quehenberger, Q. Zhang, M.J.O Wakelam, G. Haemmerle, F. Spener, H.C. Köfeler, G.G. Thallinger. DOI 10.1038/nmeth.4470, Link: http://doi.org/10.1038/nmeth.4470. *equal contribution

The current publication in Nature Methods was supported by the project "LDA - High Throughput Identification of Lipid Molecular Species in LC MS/MS Data", which ends on 30 October 2017, coordinated by Gerhard Thallinger at TU Graz and financed by the Austrian Science Fund FWF. Furthermore, the project was collaborative work of researchers from TU Graz, Med Uni Graz and Uni Graz within the framework of the BioTechMed-Graz initiative.

This research topic is anchored in the Field of Expertise "Human & Biotechnology", one of the five strategic research foci at TU Graz.

Contact:

Gerhard THALLINGER
Dipl.-Ing. Dr.techn.
TU Graz | Institute of Computational Biotechnology
Phone: 43-316-873-5343
Email: gerhard.thallinger@tugraz.athttp://genome.tugraz.at

Jürgen HARTLER
Dipl.-Ing. Dr.techn.
TU Graz | Institute of Computational Biotechnology
Phone: 43-316-873-5322
Email: juergen.hartler@tugraz.at

Graz University of Technology

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.